Latest news

Thumbnail image for  EU ‘yes’ for Bavencio

EU ‘yes’ for Bavencio

The approval was based on positive interim results from the Phase III JAVELIN Renal 101 study.

29th October 2019

Thumbnail image for Late-stage success for Imfinzi in NSCLC

Late-stage success for Imfinzi in NSCLC

The AstraZeneca human monoclonal antibody binds to PD-L1 and blocks the interaction of PD-L1 with PD-1 and CD80, countering a tumour's immune-evading tactics.

29th October 2019

Previous  --   4 5 6 7 8 9 10 11 12 13   --  Next

Latest jobs

View all

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download